Cell division is regulated by protein kinases of the Cdk, Polo, and Aurora families [1] . Although it has long been established that temporal control is central to the coordinated action of these kinases, the importance of spatial regulation has only recently been appreciated and is still poorly understood [2, 3] . The kinesin-6 family motor protein MKlp1 is a key regulator of cytokinesis [4] and an ideal substrate for studying spatially regulated protein-phosphorylation events. MKlp1 is negatively regulated by Cdk1 phosphorylation during metaphase and becomes activated in anaphase when cleavage-furrow assembly commences [5, 6] . Aurora B phosphorylates MKlp1 during anaphase and is required for its function in cytokinesis [7] . Another kinesin-6 family motor, MKlp2, mediates the relocation of Aurora B from the centromeres to the central spindle at the onset of anaphase [8] . We now demonstrate that this process is required for the phosphorylation of MKlp1 at S911, an Aurora B consensus site overlapping a bipartite nuclear localization sequence (NLS) [9] . MKlp1 S911A targets to the central spindle but is prematurely imported into the nucleus and fails to support cytokinesis. Spatial restriction of Aurora B to the central spindle by MKlp2 therefore regulates MKlp1 during cytokinesis in human cells.
Results and Discussion
Aurora B Phosphorylates Human MKlp1 at S911 within Its NLS MKlp1/CHO1 is phosphorylated at a number of sites in mitosis ( Figure 1A ) [5, 7, 10] . For simplicity, the phosphorylated sites are numbered according to the longest splice variant of human MKlp1; this splice variant is often referred to as CHO1 [11] . Two sites in the C-terminal stalk region closely match the proposed consensus motif for the Aurora B kinase [12] , and phosphorylation of one of these S812 (equivalent to S708 of MKlp1) by Aurora B has been suggested to be important for controlling the late stages of cytokinesis [7] . To further investigate phosphorylation of MKlp1 by Aurora B, and the role MKlp2 might play in this, phospho-specific antibodies were raised against both of these sites. Although the antibody to S812 specifically recognized the phosphopeptide antigen, it did not recognize endogenous MKlp1 during mitosis or phosphorylated recombinant MKlp1 by Western blotting or cell staining, and this site was therefore not followed further (our unpublished observations). In contrast, the phospho-specific antibody to S911 (pS911) gave central spindle staining during anaphase and midbody staining during cytokinesis as expected for MKlp1 ( Figure 1B) . Pre-incubation of the antibody with the phospho-peptide antigen but not the dephosphorylated peptide resulted in the loss of staining of both the central spindle and the midbody ( Figure S1A in the Supplemental Data available with this article online). In cells depleted of MKlp1, both MKlp1 and pS911 staining were strongly reduced in comparison to control cells ( Figure 1C ). This is not due to complete loss of the central spindle structure because, consistent with previous reports [8, 13] , MKlp1 depletion did not prevent targeting of MKlp2 ( Figure 1C ). Western blotting of total HeLa extracts shows that the pS911 antibody recognizes both MKlp1 and CHO1 and does not cross-react with other phosphoproteins (Figure 1D) . Like MKlp1 itself, the pS911 signal is enriched in mitotic compared to interphase cell extracts, and it is abolished by phosphatase treatment of the sample ( Figure S1B ). Furthermore, analysis of HeLa cells arrested in S phase but then allowed to proceed synchronously through mitosis confirmed that S911 phosphorylation peaks at 10.5-11 hr when the cells entered anaphase ( Figure 1E ). This was slightly later than the peak of cyclin B1, which peaked at 9-10 hr when the majority of cells were in metaphase and declined thereafter ( Figure 1E ). Together, these data show that MKlp1 is phosphorylated on S911 during anaphase and cytokinesis, and S911 is therefore a good candidate for a site regulating MKlp1 function.
To discover if Aurora B is the sole kinase capable of generating the pS911 epitope, we treated MKlp1 with Plk1, Cdk1/cyclin B, Cdk1/cyclin B/Cks1, or Aurora B/ INCENP. The pS911 antibody was only able to detect MKlp1 treated with the Aurora B/INCENP complex ( Figure 2A, pS911) , despite the facts that equal amounts of MKlp1 were loaded in all lanes and all kinases were able to phosphorylate MKlp1 as expected ( Figure 2A , MKlp1 and [ 32 P]). Mutation of S911 to alanine strongly reduced the phosphorylation of MKlp1 by Aurora B (Figure 2B) , suggesting that S911 is a major site recognized by this kinase. Furthermore, depletion of Aurora B or treatment of cells with the Aurora B inhibitor ZM447439 [14] resulted in a complete loss of pS911 staining in anaphase cells (Figures 2C and 2D) . A previous study of hamster MKlp1/CHO1 reported that Plk1 phosphorylates S911 (S904 is the equivalent position in the hamster protein) [10] ; however, this seems unlikely for a number of reasons. First, the sequence around the site matches the Aurora B consensus and not that for *Correspondence: barr@biochem.mpg.de Plk1 [3] . Second, the data presented here are consistent with a second, independent study [7] showing that a similar sequence at S812 is also an Aurora B site. We therefore conclude that Aurora B phosphorylates MKlp1 at S911, both in vitro and in vivo, during anaphase.
(E) HeLa cells were synchronized with a double thymidine block. Extracts prepared at the times indicated after the release of the block were Western blotted for MKlp1, MKlp1 pS911, a-tubulin, and cyclin B. Metaphase cells peaked between 8 and 10 hr, anaphase cells between 10 and 11 hr, and cells undergoing cytokinesis between 11 and 11.5 hr. S911A , and buffer alone (control) were treated with Aurora B/INCENP and radioactive ATP for 40 min, then analyzed by SDS-PAGE and autoradiography ([ 32 P]). The input was analyzed by Western blotting with antibodies to MKlp1. (C) HeLa cells treated with lamin A or Aurora B siRNA for 24 hr were fixed and then stained for MKlp1 pS911 (red) and either Aurora B or a-tubulin (green). To emphasize that pS911 staining is no longer present on the central spindle in Aurora B-depleted cells, we made exposure times for pS911 250 ms in the upper panel and 2000 ms in the lower panel. A 500 ms exposure time was used for Aurora B in both panels. (D) HeLa cells were treated for 5 min with 10 mM of the Aurora B inhibitor ZM447439, fixed, and then stained for MKlp1 or pS911 (red) and for atubulin (green). DNA was stained with DAPI (blue), and the scale bar represents 10 mm.
MKlp1 S911 Phosphorylation by Aurora B Requires MKlp2
MKlp2 is required for relocation of Aurora B from the centromeres to the central spindle in anaphase [8] . This raises the intriguing possibility that MKlp2 could control the phosphorylation of Aurora B substrates, including MKlp1, by regulating Aurora B targeting. In anaphase cells, MKlp2, Aurora B, and pS911 showed a similar pattern of localization to the central spindle ( Figure 3A) . In MKlp2-depleted cells, Aurora B remained on the centromeres and failed to relocate to the central spindle, and pS911 but not MKlp1 staining was lost ( Figure 3B ). This is consistent with the idea that central-spindle localization of Aurora B is needed for it to be able to phosphorylate MKlp1 and that MKlp2 is not required for MKlp1 targeting during anaphase. Phosphorylation of CENP-A, an Aurora B substrate at the centromere in metaphase cells [15, 16] , is not altered upon MKlp2 depletion (Figures 3A and 3B ; Figure S2 ), supporting the idea that MKlp2 is only required for Aurora B localization and function in anaphase cells.
To demonstrate that this is a specific function of MKlp2, we investigated the effects of depleting the central-spindle matrix protein PRC1 ( Figure 3C ). In the absence of PRC1, central spindle microtubule bundles spread out toward the cell cortex, and the associated motor proteins and mitotic kinases are reported become disorganized [17, 18] . As expected, central-spindle microtubules became disorganized, and MKlp2 and Aurora B, although still present between the retreating chromosomes, failed to form a focused band at the central spindle in anaphase cells depleted of PRC1 (Figure 3C) . In contrast to MKlp2-depleted cells ( Figure 3B ), pS911 still stained the central spindle, although the intensity was reduced, consistent with the idea that MKlp1 requires PRC1 for proper targeting to the central spindle.
S911 Phosphorylation Controls Nuclear Import of MKlp1 in Cytokinesis
To investigate the function of MKlp1 phosphorylation by Aurora B, we transfected cells depleted of endogenous MKlp1 with GFP-tagged MKlp1 (Figure 4) . Depletion of MKlp1 caused a cytokinesis defect ( Figure 4A ), and this was rescued by expression of wild-type GFPtagged MKlp1 but not the empty vector control or the MKlp1 S911A Aurora B site mutant ( Figure 4A ). As previously reported, the MKlp1 T8A Cdk1 site mutant also failed to support cytokinesis ( Figure 4A ), and it actually enhances the MKlp1 depletion phenotype, probably by interfering with spindle microtubule function in metaphase [5] . Both MKlp1 and MKlp1 S911A target to the central spindle in anaphase, but the staining for pS911 was only rescued in wild-type and not MKlp1 S911A -expressing cells ( Figure 4B ). Interestingly, no obvious defect in cleavage-furrow ingression or the targeting of other central-spindle components could be observed (our unpublished observations). This raises the question of what aspect of MKlp1 function this phosphorylation is regulating. MKlp1 is sequestered in the nucleus during interphase because of the action of a C-terminal NLS overlapping the Aurora B site at S911 [9, 19] (Figure 1A ), but it needs to remain at the midbody during cytokinesis in order to promote cell division [11] . Because S911 falls within the first part of a bipartite NLS, Aurora B phosphorylation at this site might be important for controlling nuclear localization of MKlp1 during late stages of cytokinesis once the nuclear envelope has reformed. Both wild-type MKlp1 and the MKlp1 S911A mutant can localize to the nucleus in interphase cells depleted of endogenous MKlp1 (Figure 4C ), indicating that the S911A mutation does not inactivate the NLS. As expected, MKlp1
S911A -expressing cells are binucleated ( Figure  4C) ; this protein does not rescue the cytokinesis defect caused by the depletion of MKlp1 ( Figure 4A ). During cytokinesis, endogenous MKlp1 is present on the midbody but is excluded from the nucleus ( Figure S3) . In contrast to wild-type MKlp1, which showed the same behavior as the endogenous protein when expressed from a rescue construct ( Figures 4D and S3 ), MKlp1 S911A failed to be retained efficiently on the midbody during cytokinesis and instead accumulated at the nucleus ( Figure 4D ).
The initial formation of a central spindle and midbody structure in MKlp1
S911A
-expressing cells ( Figures 4B and  4D ) suggests that phosphorylation of S911 by Aurora B is not required for these earlier events. This is different from the case in cells depleted of MKlp1 or other central spindle components such as PRC1 and MKlp2; in these cells, cleavage-furrow ingression is either not observed or highly asymmetric, and midbodies fail to form [6, 9, 11, [18] [19] [20] . Perturbation of Aurora B function gives rise to a more complex phenotype because it is required for efficient chromosome segregation as well as normal progression through anaphase and cytokinesis [7, 8, 21, 22] . This has made it difficult to identify specific functions for Aurora B during cytokinesis. The data presented here suggest that one specific function of Aurora B is to regulate MKlp1 during the late stages of cytokinesis by phosphorylating it on S911 and that MKlp2 is required for this to occur.
Control of MKlp1 Function by MKlp2 and Aurora B
MKlp2 is a conserved vertebrate kinesin-6 family motor protein essential for the cytokinesis of human cells [8, 23] . Although a homolog, Subito, is present in the metazoan invertebrate D. melanogaster, where it is required for the targeting of Aurora B to the meiotic central spindle [24] , C. elegans appears to lack MKlp2. As Kuriyama previously commented, although the NLS-containing C terminus of mammalian MKlp1/CHO1 is required for cytokinesis, this region is absent from the C. elegans homolog ZEN-4 [9] . Furthermore, the Aurora B site we have identified here falls within the bipartite NLS-containing region, suggesting that this regulatory mechanism is specific for vertebrates and either does not occur in C. elegans or involves a different mechanism. Aurora B also controls MKlp1 function at a second site, S812 in the tail region downstream of the actin binding domain, and this site is conserved in C. elegans ZEN-4, where it is required for regulation of the late stages of cytokinesis [7] . Whether MKlp2 is also required for phosphorylation of this site by Aurora B in human cells and for phosphorylation of other Aurora B targets, such as Cyk-4 [25] , at the central spindle will be an interesting topic for further investigation. Because PRC1, MKlp1, and pS911 antibodies were all raised in rabbit, it was not possible to perform costaining with them, and a mouse monoclonal antibody to a-tubulin was used instead (C). The first and middle column of each panel corresponds to the red and green colors, respectively, in the merged image in the last column, except in the top three rows of panel (C), where the first and middle columns correspond to the green and red colors of the merged images, respectively. In all panels, DNA was stained with DAPI (blue), and the scale bar represents 10 mm.
Experimental Procedures
Antibody Reagents Antibodies were as follows: DM1a 1 mg/ml mouse monoclonal to alpha-tubulin (Sigma-Aldrich, Taufkirchen, Germany), AIM-1 0.25 mg/ml mouse monoclonal to Aurora B (BD Transduction Laboratories, Heidelberg, Germany), SC-867 0.2 mg/ml rabbit polyclonal to human MKlp1 (Santa Cruz Biotechnology, Heidelberg, Germany), affinity purified 0.14 mg/ml rabbit polyclonals to the human MKlp1 motor domain (rabbits #408700 and 408701), affinity purified 0.5 mg/ml rabbit polyclonal to human PRC1 (rabbits #410766 and #410760), and affinity purified 1 mg/ml sheep polyclonal to human MKlp2 [20] . Polyclonal antibodies to phosphorylated MKlp1 were raised in rabbits against a peptides pS812 CRHRRpSRSAG (rabbit #501783) and pS911 CRKRRpSSTVA (rabbit #503703) and then isolated from a protein-A purified IgG fraction of the serum over the same peptide immobilized on Sulfolink resin according to the manufacturer's instructions (Pierce Biotechnology, PERBIO Science GmbH, Bonn, Germany). Secondary antibodies conjugated to HRP, CY2, and CY3 were obtained from Jackson Immuno Research Labs (West Grove, PA).
Molecular Biology and Protein Expression
Human MKlp1/CHO1 was inserted into pEGFP-C2 (Clontech, Heidelberg, Germany), and pcDNA3.1 (Invitrogen, Karlsruhe, Germany) was modified to encode a triple-Myc or a FLAG epitope tag. Point mutants were constructed with the Quickchange mutagenesis protocol according to the manufacturer's instructions (Stratagene, Amsterdam, The Netherlands). All constructs were confirmed by DNA sequencing (Medigenomix, Martinsried, Germany). Purification of recombinant kinases and MKlp1 were performed as described previously [12, 13] .
Cell Culture, Transfection, and RNA Interference HeLa cells were cultured at 37ºC and 5% CO 2 in DME containing 10% FCS. HeLa cells plated on glass coverslips at a density of 50,000 cells/well of a six-well plate were used for plasmid transfection and RNA interference as described previously [13] . MKlp2 0 . For Western blotting, cells from three wells of a six-well plate were washed in 2 ml PBS, then lysed in 70-80 ml 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1% (weight/ volume) Triton X-100. For each lane of a minigel, 10 mg of the protein lysate was loaded.
Image Acquisition Cells to be imaged were fixed for 5 min in methanol cooled to 220ºC. For PRC1 staining, cells were fixed for 12 min in PTEMF (20 PIPES-KOH [pH 6.8], 0.2% [volume/volume] Triton X-100, 10 mM EGTA, and 2 mM MgCl 2 ) and then blocked with 2% (weight/volume) bovine serum albumin in PBS. Antibody staining was carried out for 60 min with a 1000-fold dilution of antiserum or purified antibody at a final concentration of 1 mg/ml in PBS. Coverslips were mounted in 10% (weight/volume) Moviol 4-88, 1 mg/ml DAPI, and 25% (weight/ volume) glycerol in PBS. Images were collected with an Axioskop-2 microscope equiped with a 633 Plan Apochromat oil immersion objective lens of NA 1.4 and standard filter sets (Carl Zeiss, Gö ttingen, Germany), a 1300 3 1030 pixel cooled-CCD camera (model #CCD-1300-Y, Princeton Instruments, Trenton, NY) and Metavue software (Visitron Systems, Puchheim, Germany). Images were cropped in Adobe Photoshop 7.0, then sized and placed with Adobe Illustrator 10.0 (Adobe Systems, San Jose, CA).
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